Skip to main content

Advertisement

Log in

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

  • Hepatic and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Palmer DH, Stocken DD, Hewitt H, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007;14:2088–96.

    Article  PubMed  Google Scholar 

  2. Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel H. Palmer PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmer, D.H., Stocken, D.D., Hewitt, H. et al. Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer. Ann Surg Oncol 15, 2061 (2008). https://doi.org/10.1245/s10434-008-9921-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9921-2

Keywords

Navigation